Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Thinking "Seriously, Deeply" About Range Of Approval Strategies – Hamburg

Executive Summary

FDA is considering further “modulations” of its current approaches to drug approvals in order to encourage innovation and get products to market more quickly, Commissioner Margaret Hamburg commented during a panel session at the Biotechnology Industry Organization International Convention in Washington, D.C. on June 28.
Advertisement

Related Content

FDA Vulnerable To Meddling In Climate Of Distrust – Commish Hamburg
FDA's "Entrepreneurs-In-Residence" Program Aims To Help Small Companies
FDA Approval Standards Need To Be Relaxed, Venture Capitalists Say
BIO’s "Big Ideas" For FDA Reform Are Too Big For PDUFA
BIO’s "Big Ideas" For FDA Reform Are Too Big For PDUFA
Avastin’s Breast Cancer Claim: Will FDA’s Hamburg Take A Middle Road?
NIH Translational Center To Study Cell-Based Toxicity Tests, Offer Industry Grants
No More Easy Vaccines, Merck's Gerberding Says In Call For Collaboration
Sentinel Initiative Needs Better Defined Goals, Outside Review Concludes
Lilly Hopes To Score Novel Compounds Early By Offering To Screen Discoveries

Topics

Advertisement
UsernamePublicRestriction

Register

PS053554

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel